New ablation tools battle for better heart rhythm control

NCT ID NCT07175727

Completed Disease control Sponsor: Alfried Krupp Krankenhaus Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested two non-thermal ablation systems in 100 people with paroxysmal atrial fibrillation to see which works better and is safer. Patients were randomly assigned to one of the two devices, and their heart rhythms were monitored for a year. The goal was to find out which system reduces irregular heartbeats more effectively with fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: non-thermal ablation device (pulmonary vein isolation)
What this could lead to: If one system proves safer or more effective, it could become the preferred option for controlling atrial fibrillation with fewer complications.
What could go wrong: This is a small, completed study comparing already-approved devices, so results may not apply to all patients or guarantee long-term success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (PAROXYSMAL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation paroxysmal atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (PAROXYSMAL)

Contacts and locations

Locations

Alfried Krupp Hospital

Essen, North Rhine-Westphalia, 45131, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.